Literature DB >> 17208203

Cloning, expression, and characterization of an alternatively spliced variant of human heparanase.

Nicola J Nasser1, Aaron Avivi, Moran Shushy, Israel Vlodavsky, Eviatar Nevo.   

Abstract

Heparanase is an endoglycosidase that cleaves heparan sulfate in the extracellular matrix (ECM) and hence participates in ECM degradation and remodeling. Heparanase is involved in fundamental biological processes such as cancer metastasis, angiogenesis, and inflammation. Alternative splicing in the coding region of human heparanase was not reported. Here, we report the cloning of a splice variant of human heparanase that lacks exon 5 and is missing 174 bp compared to the wild-type cDNA. Splice 5 is expressed as a 55 kDa protein compared to the 65 and 50 kDa latent and active wild-type enzyme. Splice 5 was not detected in the incubation medium of tumor cells as opposed to the wild-type latent heparanase. Splice 5 escaped proteolytic cleavage, was devoid of HS degradation activity and exhibited diffused rather than granular cellular localization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17208203      PMCID: PMC1852469          DOI: 10.1016/j.bbrc.2006.12.189

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  32 in total

Review 1.  Functions of cell surface heparan sulfate proteoglycans.

Authors:  M Bernfield; M Götte; P W Park; O Reizes; M L Fitzgerald; J Lincecum; M Zako
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

2.  Genome-wide detection of alternative splicing in expressed sequences of human genes.

Authors:  B Modrek; A Resch; C Grasso; C Lee
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

3.  Alternative splicing and genome complexity.

Authors:  David Brett; Heike Pospisil; Juan Valcárcel; Jens Reich; Peer Bork
Journal:  Nat Genet       Date:  2001-12-17       Impact factor: 38.330

4.  A genomic view of alternative splicing.

Authors:  Barmak Modrek; Christopher Lee
Journal:  Nat Genet       Date:  2002-01       Impact factor: 38.330

5.  Expression pattern and secretion of human and chicken heparanase are determined by their signal peptide sequence.

Authors:  O Goldshmidt; E Zcharia; H Aingorn; Z Guatta-Rangini; R Atzmon; I Michal; I Pecker; E Mitrani; I Vlodavsky
Journal:  J Biol Chem       Date:  2001-05-31       Impact factor: 5.157

Review 6.  Listening to silence and understanding nonsense: exonic mutations that affect splicing.

Authors:  Luca Cartegni; Shern L Chew; Adrian R Krainer
Journal:  Nat Rev Genet       Date:  2002-04       Impact factor: 53.242

Review 7.  Evolution of alternative splicing: deletions, insertions and origin of functional parts of proteins from intron sequences.

Authors:  Fyodor A Kondrashov; Eugene V Koonin
Journal:  Trends Genet       Date:  2003-03       Impact factor: 11.639

Review 8.  Alternative splicing and evolution.

Authors:  Stephanie Boue; Ivica Letunic; Peer Bork
Journal:  Bioessays       Date:  2003-11       Impact factor: 4.345

9.  Human heparanase is localized within lysosomes in a stable form.

Authors:  Orit Goldshmidt; Liat Nadav; Helena Aingorn; Cohen Irit; Naomi Feinstein; Neta Ilan; Eli Zamir; Benjamin Geiger; Israel Vlodavsky; Ben Zion Katz
Journal:  Exp Cell Res       Date:  2002-11-15       Impact factor: 3.905

Review 10.  Genomic variants in exons and introns: identifying the splicing spoilers.

Authors:  Franco Pagani; Francisco E Baralle
Journal:  Nat Rev Genet       Date:  2004-05       Impact factor: 53.242

View more
  10 in total

Review 1.  Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.

Authors:  Uri Barash; Victoria Cohen-Kaplan; Ilana Dowek; Ralph D Sanderson; Neta Ilan; Israel Vlodavsky
Journal:  FEBS J       Date:  2010-08-31       Impact factor: 5.542

2.  Post-transcriptional regulation of heparanase gene expression by a 3' AU-rich element.

Authors:  Gil Arvatz; Uri Barash; Ofer Nativ; Neta Ilan; Israel Vlodavsky
Journal:  FASEB J       Date:  2010-08-26       Impact factor: 5.191

Review 3.  Heparan sulfate proteoglycans and their binding proteins in embryo implantation and placentation.

Authors:  Catherine B Kirn-Safran; Sonia S D'Souza; Daniel D Carson
Journal:  Semin Cell Dev Biol       Date:  2007-07-31       Impact factor: 7.727

4.  A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics.

Authors:  Uri Barash; Victoria Cohen-Kaplan; Gil Arvatz; Svetlana Gingis-Velitski; Flonia Levy-Adam; Ofer Nativ; Ronen Shemesh; Michal Ayalon-Sofer; Neta Ilan; Israel Vlodavsky
Journal:  FASEB J       Date:  2009-12-09       Impact factor: 5.191

5.  Two heparanase splicing variants with distinct properties are necessary in early Xenopus development.

Authors:  Gabriel E Bertolesi; George Michaiel; Sarah McFarlane
Journal:  J Biol Chem       Date:  2008-04-07       Impact factor: 5.157

6.  Alternatively spliced Spalax heparanase inhibits extracellular matrix degradation, tumor growth, and metastasis.

Authors:  Nicola J Nasser; Aaron Avivi; Itay Shafat; Evgeny Edovitsky; Eyal Zcharia; Neta Ilan; Israel Vlodavsky; Eviatar Nevo
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

Review 7.  Heparanase: A Challenging Cancer Drug Target.

Authors:  Deirdre R Coombe; Neha S Gandhi
Journal:  Front Oncol       Date:  2019-11-28       Impact factor: 6.244

Review 8.  Markers of Toxicity and Response to Radiation Therapy in Patients With Prostate Cancer.

Authors:  Nicola J Nasser; Jonathan Klein; Abed Agbarya
Journal:  Adv Radiat Oncol       Date:  2020-10-27

9.  Clinical significance of heparanase splice variant (t5) in renal cell carcinoma: evaluation by a novel t5-specific monoclonal antibody.

Authors:  Uri Barash; Gil Arvatz; Roy Farfara; Inna Naroditsky; Ilana Doweck; Sari Feld; Ofer Ben-Izhak; Neta Ilan; Ofer Nativ; Israel Vlodavsky
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

Review 10.  Mammalian heparanase: what is the message?

Authors:  Veronique Vreys; Guido David
Journal:  J Cell Mol Med       Date:  2007 May-Jun       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.